Earnings Flash (KMTS) Kestra Medical Technologies, Ltd. Reports Q4 Revenue $28.6M, vs. FactSet Est of $26.5M
Kestra Medical Technologies (KMTS) reported a fiscal Q4 net loss late Tuesday of $0.67 per diluted share, narrowing from a loss of $2.21 a year earlier. Analysts polled by FactSet expected a loss of $0.59. Revenue for the quarter ended April 30 was $28.6 million, up from $17.2 million a year earlier. Analysts expected $26.5 million. For fiscal 2027, Kestra expects revenue of $137 million. Analysts expect $132.9 million.
Story updates
Kestra Medical Technologies (KMTS) reported a fiscal Q4 net loss late Tuesday of $0.67 per diluted share, narrowing from a loss of $2.21 a year earlier.
Analysts polled by FactSet expected a loss of $0.59.
Revenue for the quarter ended April 30 was $28.6 million, up from $17.2 million a year earlier.
Analysts expected $26.5 million.
For fiscal 2027, Kestra expects revenue of $137 million.
Analysts expect $132.9 million.